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Specificity is perhaps the most fundamental feature of  the immune process. In this era 
of cellular and molecular immunology, much attention has been focused on the nature 
and distribution of immunoglobulin  (Ig) cell  surface receptors,  but,  relatively little 
attention has been directed to their precise functional activity. It is generally assumed 
that a precursor B-cell committed to a given antigenic determinant will be activated by 
appropriate  receptor contact with that determinant giving rise to a clone of cells produc- 
ing antibody molecules of like specificity. While there is little reason to doubt certain 
basic elements of  such a proposal, there is good reason to question whether such a simple 
concept provides a comprehensive understanding of  Ig receptor participation in the B-cell 
activation process. 
Although immunization regularly elicits specific antibody, not all new Ig synthesized 
at the time of  an immune response can be accounted for as specific antibody. Askonas and 
Humphrey observed in both guinea pigs and rabbits that half or more of newly synthe- 
sized Ig regularly failed to precipitate  with immunogen (1). Moreover, Silverstein et al. 
have estimated that 95-99% of the new Ig produced by immunized fetal lambs often fails 
to react as specific antibody (2). Do these oft-ignored "nonspecific" Ig molecules represent 
the products of  clones secreting antibody of  particularly low affinity  or avidity?  Or do they 
instead represent the products of nonspecifically activated disparate clones secreting Ig 
irrelevant to the immunizing determinants? 
Insight into these fundamental questions can perhaps  best be obtained by 
studying newly synthesized Ig at the cellular level and by concentrating one's 
study on clones secreting molecules not normally detected as specific antibody. 
We have sought to do this using a  variety of hapten-specific hemolytic plaque 
techniques some of which are introduced in this report. The basic experimental 
approach has been to immunize an animal with a  single, chemically defined 
hapten  and  to  subsequently assay its lymphoid organs not only for plaque- 
forming cells (PFC) 1 reactive with that hapten but also for PFC reactive with 
other  haptens,  many of which  are  structural  analogues of the  immunizing 
hapten. 
Such an approach almost invariably reveals moderate to large numbers of 
PFC not previously detected in standard cellular studies of antibody formation. 
Abbreviations  used in this paper:  AGG, ~-alanylglycylglycine; BSA, bovine serum albumin; 
DRBC, duck erythrocytes; HBSS, Hanks' balanced salt solution; PFC, plaque-forming cells; TGG, 
N-acetyl-L-tyrosylglycylglycine. 
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Many of these PFC are representatives of clones which expanded after immuni- 
zation but  which secrete molecules unable to  lyse erythrocytes bearing the 
immunizing hapten.  Thus,  these hapten-activated clones represent antibody- 
secreting  B  cells  which  preferentially  form  plaques  on  sheep  erythrocytes 
(SRBC)  bearing structural analogues, but not on SRBC conjugated with the 
immunizing hapten.  Multispecific plaque assay procedures and hapten inhibi- 
tion techniques have provided useful information on the specificity and binding 
characteristics of the antibody molecules secreted by these analogue-reactive B- 
cell populations. The specificity data thus obtained allow initial insights into 
some of the complexities of Ig receptor participation in B-cell activation. 
Materials and Methods 
Animals.  Female New Zealand white rabbits weighing from 2 to 3 kg were obtained from the 
NIH Animal Production Unit, Bethesda,  Md. Female BALB/cN and C57BL/6N mice came from 
the same source and were used at 6-12 wk of age. 
Reagents.  SRBC were obtained from the NIH Animal Production Unit. Lyophilized guinea pig 
complement  (C) was purchased  from BioQuest Div. Becton,  Dickinson &  Co.,  Baltimore,  Md. 
Fresh rabbit  C  was harvested from New Zealand white rabbits  obtained from the NIH animal 
colony. It was held on ice and utilized in plaque assays within 2 h of acquisition. Ficoll (average 
mol wt 400,000)  was obtained from Pharmacia Fine Chemicals, Inc., Piscataway,  N. J. 
Antigens.  All the haptens employed in this study are listed in Table I. Large haptens have 
been given single capital letter designations; italicized lower case letters have been employed for 
the corresponding small haptens. 2 The procedures for synthesis of the special tripeptide-enlarged 
haptens were those reported by Inman et al.  (3). Duck erythrocytes (DRBC) were obtained from 
Stanley B. Krutulis Co., Bridgeport, N. Y., and were derivatized with the large haptens, S, A, or 
according to the  method  of Inman  et  al.  (4). A4.~-Ficoll  3 was  also  prepared  by a  procedure 
described by Inman (5). DRBC were conjugated with the small haptens, p-azobenzenearsonate  (a) 
andp-azobenzenesulfonate  (s), as described by Hanna and Merchant (6). Rabbits immunized with 
hapten-derivatized  DRBC  ordinarily  received 3  ml  of 0.1%  vol/vol hapten-derivatized  DRBC 
stromata intravenously (i.v.) on days 0,  2,  4,  8,  15, and 30.  Rabbits were rested thereafter,  and 
those rabbits assayed at later intervals were normally boosted with the same dose of antigen only 3 
days before sacrifice. Mice immunized with hapten-derivatized DRBC received 1.0 ml of 0.1% vol/ 
vol of such DRBC intraperitoneally (i.p.) on day 0 and were assayed for splenic PFC on day 4. Mice 
immunized with haptenated Ficoll received 10 ~g of A4.~-Ficoll i.p. on day 0 and were assayed for 
splenic PFC on day 4. 
Hemolytic Plaque Procedures.  Immune cell suspensions were prepared as previously reported 
(6). For some experiments immune cell suspensions,  frozen at l°C/min and maintained in liquid 
N2, were used after rapid  thawing.  The procedures involved have been published  (7).  Hapten- 
specific PFC  were detected as previously described  (8)  except that  the agar contained  0.2  mg 
bovine serum albumin  (BSA) and l0  s U  of sodium penicillin G/ml. All hemolytic plaque assays 
were performed without the use of base agar layers. Plates usually contained from 10 to 50  ×  10  ~ 
spleen cells. The plating, incubation, plaque development, and counting conditions were identical 
with  those  previously described  (7). All data  represent the  SRBC background-corrected  mean 
values for duplicate or triplicate hapten-specific PFC assays.  A hyperimmune sheep anti-rabbit 
IgG serum was used for detection of rabbit indirect PFC. This antiserum had been raised in sheep 
after multiple monthly intramuscular  injections of an emulsion containing 0.5 mg of Sephadex- 
purified rabbit IgG in 0.5 ml of 0.15 M NaC1 and an equal volume of Freund's incomplete adjuvant. 
While enhancing or facilitating the detection of IgG-secreting PFC,  this antiserum  simultane- 
ously inhibited the appearance  of most IgM-secreting PFC.  The average degree of IgM plaque 
inhibition  was  70%  with  the  antiserum  diluted  1:100. Thus,  the  indirect hapten-speclfic  PFC 
activities have been corrected both for background  activity against  SRC, and  on an indiv,dual 
2 For letter designations corresponding to haptens see Table I. 
3 An average of 45 molecules of hapten A per 400,000  daltons of original Ficoll were covalent!y 
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basis for roughly 30% of the corresponding direct PFC activity which remained uninhibited by the 
facilitating antiserum. 
Indicator Erythrocytes.  Erythrocytes optimally derivatized with the large haptens were pre- 
pared according to the procedure of Inman et al. (4). This method normally attaches around 3 × 10  '~ 
large haptenic groups to each erythrocyte. The method of Rouques et al. (7) was employed for the 
preparation of small hapten-conjugated indicator SRBC. 
Multispecific PFC Assays.  Detection in a  single assay of two or more hapten-reactive  PFC 
populations can be accomplished by the use of SRBC bearing optimal or near optimal densities of 
two or  more haptenic  determinants  (7). In the present  experiments,  simultaneous  diazonium 
coupling of SRBC with two different azo-haptens  (e.g., a  plus s) was accomplished by using, for 
each hapten, half the quantity of reagents required for single coupling and mixing equal volumes 
of the  two  separately  prepared  conjugation  reagents just  before the  addition  of the  standard 
quantity ~f SRBC. If three, four, five, or six azo-haptens were coupled to indicator SRBC, then 1/3, 
1/4,  1/5, or 1/6,  respectively, of the quantity of reagents required for single hapten coupling were 
prepared for each hapten specificity. These were mixed in equal volumes just before addition of the 
standard  quantity  of SRBC  required  for  the  regular  conjugation  procedure  as  described  by 
Rouques  et  al.  (7). Variations  in  coupling  rates  for the  different  small  azo-haptens  probably 
prevented equivalent SRBC sensitization with each. Nonetheless the use of additional haptens in 
the coupling reaction regularly led to the detection of additional numbers of PFC. 
Hapten-Mediated  Inhibition  of Hapten-Specific  PFC.  Sulfanilic acid  (Fisher  Scientific Co., 
Fair Lawn, N. J. ) was diazotized and conjugated to BSA obtained from Miles-Pentex, Kankakee, 
Ill., by the method of Campbell et al.  (9) to yield s2~-BSA.  Arsanilic acid (Fisher Scientific Co.) 
was conjugated to BSA by the same method to yield a26-BSA.  DNP32-BSA was prepared by the 
method of Eisen et al. (10). These hapten-derivatized proteins were dissolved in 0.15 M potassium 
phosphate buffer, pH 7.5,  at a concentration of 10 mg/ml. Such multivalent inhibitors were added 
to the agar-bearing test tubes just before plating in order to yield a final concentration of 1 mg/ml 
of hapten-derivatized protein. 
Hemagglutination  Assays.  All sera were inactivated at 56°C for 30 min. Veronal-buffered 0.15 
M NaC1, pH 7.4 containing 1% normal rabbit serum was used for dilution of antiserums. Antibody 
titrations were performed in disposable multi-well plastic plates (Cooke Laboratory Products Div., 
Dynatech  Laboratories  Inc.,  Alexandria,  Va.)  employing standard  double-dilution procedures. 
The hemagglutination  end point was defined as the reciprocal of the highest twofold dilution 
which provided visible agglutination after 2 h  at 25°C. 
Results 
General  Characteristics  of Analogue-Reactive  PFC.  Initial  experiments 
with hapten-specific hemolytic plaque assays demonstrated specificity charac- 
teristics similar to those expected. As experience accumulated, however, there 
were fairly frequent instances in which a-immunized rabbit spleen cell suspen- 
sions produced more PFC  on s-coupled SRBC  than on a-coupled SRBC,  and 
conversely  s-immunized rabbit spleen cell suspensions often produced more PFC 
on a-coupled SRBC than on s-coupled SRBC. In addition, spleen cell suspensions 
obtained from rabbits immunized repeatedly for weeks or months with a single 
azo-hapten would often produce indirect PFC responses specific for the immuniz- 
ing hapten while their coexisting direct PFC responses would be predominantly 
directed against the alternate hapten. Such provocative findings could not be 
ignored. 
In order to gain a more comprehensive insight into the functional specificity of 
PFC populations, various types of indicator SRBC were prepared, each bearing 
a different azobenzenoid hapten. Immune cell suspensions from rabbits immu- 
nized with a  single azo-hapten were then examined in separate but parallel 
assays for the presence of PFC reactive with each of six or seven different azo- 
haptens. The azo-haptens chosen were selected to be either closely or distantly BRUCE  MERCHANT  AND  JOHN  K.  INMAN  375 
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FIo.  1.  Splenic direct hapten-specific PFC activities in azo-hapten immunized and control 
rabbits. Each histogram profile represents the activities detected in a single rabbit spleen. 
The arrows identify the hapten used for immunization.  The haptens corresponding to the 
small  letter  designations  are identified  in Table I. Rabbit A was not immunized; B was 
assayed on day 33 after being immunized with 3 ml of 0.1% DRBC carrier only on days 0, 2, 
4, 8, 15, and 30; C and D were each assayed on day 33 after being repeatedly immunized with 
3 ml of 0.1% s-DRBC according to the same schedule; E and F were both immunized with a- 
DRBC and given six injections in the 1st mo as above. E was assayed 3 days after a boost at 
28 mo and F was assayed 3 days after a boost at 8 mo. 
~9 
Z 
C 
C~ 
8 
m 
Z 
related analogues of the arsonate- and/or sulfonate-immunizing haptens. Immu- 
nization with  a  single hapten usually elicited  PFC  populations detectable  not 
only on SRBC bearing that hapten, but also on SRBC bearing both closely and 
distantly related haptenic structures. 
The  data  assembled  in  Fig.  1  records  findings  that  are  typical  for  direct 
hapten-reactive  PFC  activities  detectable  in spleen  cell  suspensions  of immu- 
nized  and  control  rabbits.  Each  histogram  bar  represents  the  PFC  activity 
obtained with indicator SRBC bearing a single azo-hapten. Although none of the 
haptens  employed  are  known  to  exist  in  nature,  spleen  cells  from  normal, 
unimmunized adult animals invariably had background PFC activities against 
most or all assay haptens as depicted by rabbit A  in Fig.  1. After correction for 
anti-SRBC  activity,  such  background,  hapten-specific  PFC  counts  normally 
ranged from 2 to 8 per 106 nucleated spleen cells,  as compared with background 
activities  against  SRBC  which  normally  ranged  from  1  to  5  per  106  cells. 
Immunization  with  a  nonhaptenated  carrier  antigen  (DRBC),  (rabbit  B) pro- 
duced  at  most,  only minor  fluctuations  in these  background,  hapten-reactive 
direct  PFC  activities.  In the great  majority  of instances,  background  hapten- 
specific,  indirect PFC  were  either absent or so low as to escape  detection,  i.e., 
less than one indirect PFC per 106 nucleated cells. 
The histograms for rabbits C and D  are typical of the hapten-reactive,  direct 
PFC  responses  of rabbits repeatedly  immunized  with s-DRBC.  The histogram 
profiles for these two unrelated rabbits show marked similarities,  and as might 376  DETECTION  OF  ALLOEEACTIVE  PLAQUE-FORMING  CELLS 
be expected, the number of PFC detected on SRBC bearing the meta isomer of 
azobenzenesulfonate (w) is the second highest PFC activity detected. Typically 
also, the PFC activities observed for indicator SRBC bearing structurally dis- 
tant analogues such as the p-azobenzophenone (y) and the p-bromophenylazo 
(u) haptens were also rather surprisingly high. The question that comes imme- 
diately to mind is whether the PFC detected on SRBC bearing hapten analogues 
represent subcomponents of the PFC population detected on s-SRBC or whether 
they represent separate and distinct PFC populations.  It is also important to 
determine whether azo-hapten immunization invariably generates complex, 
diverse, hapten-reactive PFC responses or whether monospecific PFC responses 
are sometimes elicited. 
That monospecific, direct PFC responses can occur which are detected only by 
erythrocytes  bearing the immunizing hapten is apparent from the histogram for 
rabbit E which was rested for over 2 yr before a final booster immunization with 
a-DRBC.  That all analogue-reactive PFC populations are not necessarily sub- 
compartments of the specific PFC population is also apparent from the histo- 
gram for rabbit F which was assayed after a final a-DRBC boost at 8 mo. More 
PFC were seen on SRBC coupled with s or w, and nearly four times more on p- 
azobenzoate  (v)-coupled  SRBC  than  were  seen  on  SRBC  coupled  with  the 
immunizing hapten. In the occasional instances, of which rabbit F is typical, it 
is most unlikely that the s-, w-, or v-reactive PFC comprise subcompartments of 
the a-SRBC-reactive PFC population. 
Evaluation  of PFC Reactivity  Directed  to  Common  Structural  Components 
Shared by Homologue- and Analogue-Coupled SRBC.  The specificity of ana- 
logue-reactive, direct PFC  populations  as  seen for the v-reactive PFC  from 
rabbit F of Fig.  1 might be directed almost exclusively against "bridge compo- 
nents,"  common to  all  the  haptenic structures employed, and comprising a 
phenylazo group attached to the subjacent amino acid components of the eryth- 
rocyte protein. However, these same structural features were present in the t-, 
y-, and u-SRBC  which yielded only small numbers of plaques. In order to test 
further for the possibility of erythrocyte  component contribution to reactivity, a 
series of enlarged azo-haptens were prepared (3). These haptens were designed 
to  approximate  the  size  of the  average antibody-combining site,  and  they 
consisted of a tripeptide "stem" to which terminal azo-haptens were attached. 
When converted to reactive azides,  these enlarged haptens coupled predomi- 
nately to epsilon amino groups of lysine residues present in erythrocyte surface 
proteins (4). Two separate series of enlarged haptens were prepared. One series 
shared a common acetyl-tyrosylglycylglycine  (TGG) stem such that aider conju- 
gation it represented a haptenated TGG-lysine determinant. The other series 
shared a  fl-alanylglycylglycine (AGG)  stem such that  after conjugation,  its 
members represented haptenated AGG-lysine determinants (see Table I). For 
the haptenated TGG series, an unsubstituted acetyl-tyrosylglycylglycine  hapten 
(G) served as a useful specificity control. 
By employing both the small and the corresponding large azo-hapten indica- 
tor SRBC  systems in parallel it was possible to evaluate the contribution of 
erythrocyte structures to PFC  reactivity. If much of the PFC  specificity was 
actually directed against erythrocyte-contributed  components of  the conjugation 
regions,  (which conceivable might be shared by SRBC  and DRBC)  then the BRUCE  MERCHANT  AND  JOHN  K.  INMAN 
TABLE I 
Single-Letter Symbols and Chemical Designations* for Haptens 
Employed in This Study 
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Small haptens 
a  = p-azobenzenearsonate 
s  = p-azobenzenesulfonate 
w  =  m-azobenzenesulfonate 
o  = o-azobenzenesulfonate 
v  =  p-azobenzoate 
y  =  p-azobenzophenone 
u  = p-bromophenylazo 
t  =  p-azobenzenesulfonamide 
Large haptens 
TGG Series 
A  =  3-(p-arsonophenylazo)-N-acetyl-L-tyrosylglycylglycine 
S  =  3-(p-sulfophenylazo)-  "  " 
W  =  3-(rn-sulfophenylazo)-  "  " 
O  =  3-(o-sulfophenylazo)-  "  " 
V  =  3-(p-carboxyphenylazo)-  " 
Y  =  3-(p-benzoylphenylazo)-  " 
U  =  3-(p-bromophenylazo)-  "  " 
T  =  3-(p-sulfamylphenylazo)-  " 
M  =  3-(p-trimethylaminophenylazo)-  " 
dp  =  3-phenylazo-  "  " 
G  =  (3-unsubstituted)-  "  " 
AGG  Series 
J  = N-(2,4-dinitrophenyl-fi-alanylglycylglycine 
K  = N-(2,4,6-trinitrophenyl)-/]-alanylglycylglycine 
D  = N-(5-dimethylaminonaphthalene-l-sulfonyl)-fl-alanylglycylglycine 
Z  = N-benzyloxycarbonyl-/3-alanylglycylglycine 
* Structural formulae for the large haptens are presented in reference 3. Each 
small hapten has the same structure as the substituted phenylazo portion of 
the large hapten designated with the corresponding upper case letter. 
erythrocyte contribution should be substantially disrupted by the interposition 
of a tripeptide spacer. Fig. 2 presents typical direct and indirect hapten-reactive 
PFC profiles obtained for both small hapten-coupled and large hapten-coupled 
indicator SRBC from a rabbit immunized repeatedly for 1 mo with s-DRBC. The 
incidence of analogue-reactive  PFC is not reduced by the use of large hapten 
PFC assay systems.  On the contrary, each large hapten assay system consist- 
ently detected  more PFC than the corresponding small hapten assay system. 
Since only very few PFC can be detected using the nonhaptenated TGG tripep- 
tide (G),  it is apparent that most of the PFC antibody reactivities are directed 
against the distal or azo-hapten-defined termini of the large hapten molecules. 
If, however, the large PRC responses to W and A  (Fig. 2) represented antibody 
directed against a phenylazotyrosyl "bridge,"  present as a portion of the small 
hapten-immunizing determinants,  (and simply amplified in the large hapten 
assay system by a "spacing-out" effect), then the response to O, which shares 
this structure,  should also have been large. 4 Thus, it seems improbable that 
4 Many additional examples of coexisting high and  low PFC  responses to  different haptens 
sharing a  phenylazotyrosyl bridge have been obtained  and  will be  reported elsewhere.  These 
results include  instances  in which a  low response was detected with the unsubstituted phenylazo 
hapten, along with high responses to several of the other analogue haptens. 378  DETECTION  OF  ALLOREACTIVE  PLAQUE-FORMING  CELLS 
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Fro.  2.  Splenic PFC activities as discerned on small vs. large hapten-conjugated indicator 
SRBC. The various histograms represent the direct and indirect PFC activities detectable 
using either the large or the small hapten assay systems with the same rabbit spleen cell 
suspension. The  haptens corresponding to  the  large  and  small  letter  designations are 
identified in Table I. This rabbit's spleen was assayed on day 33 after immunization with 
repeated i.v. injections of 3 ml of 0.1% s-DRBC on days 0, 2, 4, 8,  15, and 30. 
analogue-reactive PFC populations are producing antibody that is exclusively 
directed against ~'bridge areas." 
Analogue-Reactive  PFC Responses  in Mice.  In addition to affording more 
reliable detection of hapten-reactive PFC populations, the increased sensitivity 
afforded by the large hapten assay systems had two other major effects. First, 
background, direct PFC activities increased on the order of 5- to 10-fold, thus 
permitting increased experimental inquiry into the nature and specificity of 
background,  direct  PFC  populations.  Some of this  work has  been  reported 
elsewhere (11). Second, when used in conjunction with large hapten immuniza- 
tion, the large hapten assay systems allowed the ready detection of hapten- 
reactive PFC responses in mice, a capability possible for haptens like trinitro- 
phenyl, but previously unattainable with small azo-hapten assay systems. Fig. 
3 records the 4-day primary, direct PFC profiles of both BALB/c and C57BL/6 
mice  elicited  in  response  to  ¢P-DRBC. The  diversity  of the  PFC  activities 
detected is obvious. The similarity in the histogram profiles between these two 
strains  of mice  differing at  the  major H-2  histocompatibility locus  is  also 
striking. Immunization with a single, enlarged hapten has resulted in increased 
PFC activity for most of the enlarged haptenic specificities under test. Although 
a  direct PFC population reactive with the immunizing hapten is invariably 
present in mice as in rabbits, the %pecific" or homologue-reactive PFC popula- 
tion is by no means the most numerous single population detected. The cp. 
reactive PFC were outnumbered in BALB/c mice by PFC reactive with three 
and in C57BL/6 mice by PFC reactive with four other haptenic determinants. 
Although the S,  A,  and V haptens can be considered close analogues which 
share the stem TGG component with the immunizing cP-hapten, the enlarged BRUCE  MERCHANT  AND  JOHN  K.  INMAN  379 
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FIG.  3.  Direct,  hapten-specific PFC  activities in mice immunized with ~-DRBC.  Each 
histogram represents the activities detected in a  cell suspension prepared from a  pool of 
seven mouse spleens. Each bar represents the mean of duplicate assays for a given haptenic 
specificity after correction for background PFC against SRBC.  BALB/cN and C57BL/6N 
mice were immunized i.p. with a  1.0 ml of 0.1%  ¢-DRBC on day 0 and assayed on day 4. 
Unimmunized control mice were assayed on the same day and their SRBC-corrected splenic 
PFC activities are shown as background histograms. 
trinitrophenyl hapten, K, must be considered less closely related not only at its 
terminus, but  also because it  contains an  AGG rather than a  TGG "stem" 
component.  PFC  against  other  relatively disparate  structures  such  as  the 
trimethylaminophenylazo-TGG  (M) and the dansyl-AGG (D) haptens also often 
show detectable increases after ¢P-DRBC immunization. 
Are Analogue-Reactive PFC Representative of Hapten-Elicited Humoral Im- 
mune Responses?  Consistent findings such as these served to raise the ques- 
tion whether antibody activities measured as PFC might reflect some spurious 
laboratory artifact unique to hemolytic plaque assay systems. To i,.avestigate 
this possibility, rabbits were immunized repeatedly with ¢-DRBC, and their 
splenic PFC  and serum hemagglutinin titers were compared on day 18.  ~P- 
DRBC-immunized rabbits are often uniquely slow in converting to IgG produc- 
tion.  At  this  stage,  these  rabbits  were  still  committed exclusively to  IgM 
responses, and no indirect PFC  were detectable. Serum obtained from these 
rabbits at sacrifice was assayed by passive hemagglutination on large hapten- 
conjugated SRBC. With only occasional exceptions, hapten-reactive PFC levels 
correlated well with serum titers (Fig.  4). In all instances, the hapten-reactive 
PFC responses were extremely diverse. In rabbit A both the PFC and serum 
titer activities against analogue haptens often exceeded the activities demon- 
strable on SRBC bearing the immunizing hapten, ¢P. 
As in mice, the rabbit PFC activities against more disparate haptens such as 
those PFC  reactive with the Y,  D, J,  and K  haptens substantially exceeded 
background, direct PFC activities. (Background PFC activities detected on large 
hapten-coupled SRBC  usually range from 1 to 20 per 10  s spleen cells in most 
unimmunized rabbits.  The hapten-specific hemagglutination titers for preim- 
mune bleedings from rabbits A and B ranged from <2 to 4.) Thus, immunization 380  DETECTION  OF  ALLOREACTIVE  PLAQUE-FORMING  CELLS 
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Fia.  4.  General correlation between splenic, direct PFC values, and serum hemagglutina- 
tion titers.  The  shaded  histograms,  A  and  B,  represent  the  PFC  activities detected  in 
separate rabbit spleens.  Each shaded bar represents the mean of triplicate assays for a 
given haptenic specificity aRer correction for background PFC against SRBC.  Each open 
bar represents the reciprocal of  the hemagglutination titer  obtained for a given haptenic 
specificity. Rabbits A  and B  were each immunized with repeated i.v. injections of 3 ml of 
0.1% dP-DRBC on days 0, 2, 4, 8, and 15 and their spleens were assayed on day 18. Blood for 
serum hemagglutination titers was drawn about 5 rain before acquisition of the spleens. 
of rabbits with a  single,  large haptenic determinant regularly generated in- 
creased PFC  and hemagglutinating activities  against  most of the  enlarged 
haptenic determinants tested. Such findings indicate that the diverse analogue- 
reactive PFC detected are the source of diverse humoral antibodies formed in 
response to immunization. 
It is also relevant to inquire whether some vagary in C binding attributable to 
the heterologous activation of  guinea pig C by rabbit Ig might impose a mislead- 
ing impression of PFC response diversity. Accordingly, PFC from ~-immunized 
rabbits were compared using either lyophilized guinea pig serum or fresh rabbit 
serum as separate sources ofC. A typical result is illustrated in Fig. 5. Apprecia- 
ble variations in response specificity were encountered using the separate C 
sources;  however,  guinea pig  C  appears  to  constitute,  if anything,  a  more 
conservative system for the evaluation of PFC response diversity. 
Are Analogue-Reactive and Homologue-Reactive PFC Cross-Reacting or Mu- 
tually Exclusive?  Since analogue-reactive and homologue-reactive PFC were 
detected on separate assay plates, it was important to ascertain whether they 
represented largely overlapping "cross-reactive" PFC populations, or whether 
they represented coexisting but mutually exclusive PFC responses. There are 
several potential experimental approaches to this question.  ~ For the present 
some early plaque inhibition experiments utilizing the small azo-hapten assay 
systems are given below.  Table II records the results of a typical experiment 
performed with direct hapten-reactive PFC from a rabbit immunized repeatedly 
with s-DRBC.  Direct PFC  reactive with the immunizing hapten s  were the 
largest single hapten-reactive plaque population detected; a- and t-reactive PFC 
were also numerous. When combinations of two or more haptenic analogues 
5 Merchant, B., and J. K. Inman. Manuscript in preparation. BRUCE  MERCHANT  AND  JOHN  K.  INMAN  381 
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FIG.  5.  Detection of direct hapten-specific rabbit PFC with either rabbit or guinea pig C. 
Both histograms represent the PFC activities detected using the same rabbit spleen cell 
suspension. This rabbit had been immunized i.v. with 3.0 ml of 0.1% cP-DRBC on days 0, 2, 
4, 8, and 15, and its spleen cell suspension was assayed on day 18. Like rabbits A and B of 
Fig. 4, at this juncture it had no detectable indirect PFC.  The data have been normalized 
and are presented as the percent of the specific PFC response to cp, the immunizing hapten. 
The hemolytic efficiency of lyophilized guinea pig C was greater than that of fresh rabbit C. 
Guinea pig C detected 977 anti-cP PFC per 10  e nucleated spleen cells while rabbit C detected 
only 439 anti-cP PFC per 106 nucleated spleen cells. 
were coupled to SRBC, additive (but less than fully summative) PFC activities 
were detected. When these PFC were exposed to equal concentrations of multi- 
valent haptenated BSA inhibitors variable numbers of PFC were inhibited.  In 
all instances,  BSA alone or DNP-BSA had little  inhibitory effect. Sulfonate- 
reactive PFC were well inhibited by s29-BSA and arsonate-reactive PFC were 
well inhibited by a~-BSA. However, a2s-BSA was, at best, a weak inhibitor of 
s-reactive PFC and s29-BSA was a weak inhibitor of a-reactive PFC. Thus, the 
reactivity of a  given analogue-reactive PFC population can be higher for the 
analogue test hapten than for the original immunizing or homologue hapten. 
The t-reactive PFC were also moderately well inhibited by a~-BSA but were not 
inhibited by s29-BSA. 
With multi-haptenated indicator SRBC, s29-BSA was often a better inhibitor 
than a26-BSA but it became a progressively less effective inhibitor as additional 
haptens were added to the indicator SRBC. Multi-haptenated SRBC bearing six 
different azo-haptens provided detection of  approximately twice as many PFC as 
could be detected by SRBC bearing just the immunizing  homologue s.  Only 
about half of these  PFC  could be inhibited  by s29-BSA, and  a26-BSA was a 
comparably effective inhibitor. 
Table III reports a similar experiment performed with the direct PFC obtained 
from a rabbit immunized repeatedly with a-DRBC. In this instance, more PFC 
were detectable on s-conjugated SRBC than on SRBC bearing the immunizing 
homologue, a. Again, conjugation of  both these haptens to indicator SRBC led to 
additive (but less than fully summative) numbers of direct PFC. Conjugation of 382  DETECTION  OF  ALLOREACTIVE  PLAQUE-FORMING  CELLS 
TABLE  II 
Hapten Inhibition Studies of Direct Analogue-Reactive PFC from a s-DRBC 
Immune Rabbit* 
No. of hapten-reac- 
Indicator red cells$  rive PFC/10  ~ spleen 
cells§ 
Inhibiting antigen 
(1  mg/ml)  % of PFC inhibition 
s -SRBC  2,402  None  - 
"  BSA  8 
"  DNP3sBSA  0 
"  a~6BSA  17 
"  s2sBSA  94[] 
a -SRBC  913  None  - 
"  BSA  0 
"  DNP32BSA  0 
"  a26BSA  100 
"  s29BSA  9 
t-SRBC  1,994  None  - 
"  BSA  16 
"  DNP3~BSA  0 
"  a~eBSA  65 
"  s29BSA  0 
a -SRBC-s  2,930  None  - 
"  BSA  1 
"  DNP32BSA  0 
"  a2eBSA  73 
"  s29BSA  7611 
s  o  4,372  None  - 
SRBC  BSA  0 
w  t  DNP~2BSA  10 
"  a~6BSA  72 
"  s~gBSA  5311 
s  v  o  4,924  None  - 
SRBC  BSA  5 
w  y  t  DNP32BSA  0 
"  a28BSA  42 
"  s~gBSA  47[I 
* This rabbit's spleen was assayed on day 33 after being immunized i.v. with 3.0 ml of 
0.1% s-DRBC on days 0, 2, 4, 8,  15, and 30. 
$ The haptens corresponding to the small letter designations are identified in Table I. 
Indicator SRBC  shown in association with two  or more letters were  prepared  by 
exposure to equimolar concentrations of the reactive form of two or more haptens 
and  were  employed for multispecific  PFC  assays which allow  the  simultaneous 
detection of two or more PFC populations in a  single assay. 
§ Each value represents the mean of triplicate assays after correction for background 
PFC activity against SRBC. 
U  For  the  four  types  of indicator  red  cell  preparations  bearing  the s  hapten,  the 
computed  numbers of plaques  inhibited  by s~gBSA were  2,258,  2,227,  2,317,  and 
2,314 for s-SRBC through s  v o  w y  t-SRBC, respectively. BRUCE  MERCHANT  AND  JOHN  K.  INMAN  383 
TABLE HI 
Hapten Inhibition Studies of Direct Analogue-Reactive PFC from an a- 
DRBC Immune Rabbit* 
Indicator red cells$ 
No.  of hapten-reac-  Inhibiting antigen 
tive PFC/106 spleen 
cells§  (1  mg/ml) 
% of PFC inhibition 
a-SRBC  1,253  None  - 
"  BSA  13 
"  DNP32BSA  15 
"  a2eBSA  100 
"  s29BSA  42 
"  a26BSA +  s29BSA[[  100 
s -SRBC  1,541  None  - 
"  BSA  7 
"  DNPs2BSA  7 
"  a~sBSA  0 
"  s~BSA  79 
"  a26BSA  +  s~oBSA  83 
w -SRBC  990  None  - 
"  BSA  9 
"  DNP32BSA  10 
"  a~sBSA  60 
"  s29BSA  41 
"  a2~BSA +  s29BSA  62 
a -SRBC-s  2,356  None  - 
"  BSA  8 
"  DNP32BSA  15 
"  a2eBSA  79 
"  s29BSA  52 
"  a2~BSA  +  s29BSA  100 
s  w  3,884  None  - 
SRBC  BSA  19 
a  t  o  DNP32BSA  14 
"  a26BSA  18 
"  szgBSA  59 
"  as6BSA +  s2sBSA  53 
* The rabbit's spleen was assayed on day 33 after being immunized i.v. with 3.0 ml of 
0,1% a-DRBC on days 0, 2, 4, 8,  15, and 30. 
$ The haptens corresponding to the small letter designations are identified in Table I. 
Indicator SRBC shown in association with two or more small letters were exposed 
to  conjugation with  equimolar  concentrations  of two  or  more  haptens  and  were 
employed for multispecific PFC  assays which allow the simultaneous detection of 
two or more PFC populations in a  single assay. 
§ Each value represents the mean of triplicate assays after correction for background 
PFC activity against SRBC. 
Jl Each present at 1 mg/ml as an inhibitor. 
five different azo-haptens to indicator SRBC led to detection of more than three 
times as many PFC as could be detected on SRBC bearing only the a homologue. 
Only modest numbers of PFC were inhibited by exposure to 1 mg/ml of BSA or 
DNP32-BSA. Arsonated BSA was fully effective in inhibiting plaques detectable 384  DETECTION  OF  ALLOREACTIVE  PLAQUE-FORMING  CELLS 
on a-SRBC, but it was quite ineffective in suppressing plaques detectable on s- 
SRBC. The s-reactive PFC could be well inhibited however by s29-BSA. When 
indicator SRBC were conjugated with beth the a  and s haptens, s29-BSA could 
only inhibit about half of the PFC detected. When both a~e-BSA and s29-BSA 
were added as inhibitors,  all plaques could be inhibited. SRBC  coupled with 
each of five analogue azo-haptens could be only partially inhibited by s29-BSA 
and this inhibition was not increased by the concurrent addition ofa26-BSA. 
Possible T-Cell Participation in the Diversity of PFC Responses.  The diver- 
sity of PFC responses engendered by hapten immunization might be attributa- 
ble strictly to thymic-dependent antigens and to the consequent complexities 
afforded by T-cell participation in the humoral response. Accordingly, mice were 
immunized with the enlarged arsonate hapten, A, coupled either to the thymic- 
dependent carrier, DRBC,  or to the thymic-independent carrier, Ficoll. Fig. 6 
discloses the resulting 4-day primary, direct PFC profiles elicited in BALB/c 
mice. Although these PFC profiles show some differences, they are nonetheless 
unquestionably diverse in both instances. Thus, the direct PFC response to azo- 
haptens  appears  to  be  diverse  regardless  of whether thymic-dependent or 
thymic-independent  carrier antigens are employed. 
Discussion 
Our present data  (Tables II and III) are incompatible with the view that 
analogue hapten assay systems detect only subcomponents of the PFC popula- 
tion detected on SRBC bearing the immunizing hapten. Instead, they favor the 
view that immunization with a  single,  chemically defined azo-hapten elicits 
numerous coexisting PFC populations, each best detected either with the homo- 
logue hapten or with one or another hapten analogue conjugated to indicator 
SRBC. The data are however, consistent with the view that some overlapping 
occurs in  the  detection of these  coexistent PFC  populations  since partially 
additive rather than fully summative detection of two separate PFC response 
specificities is usually observed when SRBC conjugated with two or more sepa- 
rate azo-haptens are employed as the indicator system. 
Our present findings also indicate that the usual hapten-reactive PFC assay 
may be "seeing" only the tip of  the humoral immune response iceberg. The use of 
analogue haptens for PFC  assays reveals additional, largely nonoverlapping 
PFC populations, a circumstance  analogous perhaps to "rolling over" the iceberg 
in such a way as to expose new tips. Although numerous hapten analogues may 
be  employed to  view numerous tips  of the immune response iceberg, a  full 
populational definition of the totality of the secretory B-cell response remains 
elusive. Since early direct PFC specific for the immunizing hapten often repre- 
sent only a very minor component even of the selected populations tested for, it 
follows  that a  full comprehension of the functional specificity of Ig receptor- 
mediated participation in B-cell  activation also remains elusive. Thus, when 
only the  immunizing or  homologue hapten  is  employed for  PFC  assays  a 
question may often fairly be raised as to the actual representativeness of the 
PFC population detected. An important corollary of the foregoing is that the 
usual homologue-reactive  PFC population probably represents a restricted num- 
ber of clones. Up to now, PFC populations have been viewed as having restricted 500! 
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FIG.  6.  Hapten-specific, splenic PFC responses of BALB/cN mice to thymic-dependent and 
thymic-independent antigens. Each histogram represents the direct PFC activities detected 
in a cell suspension prepared from a pool of six mouse spleens. Each vertical bar represents 
the mean of duplicate assays for a given haptenic specificity after correction for background 
PFC against SRBC. BALB/cN mice were immunized i.p. either with 1.0 ml of 0.1% A-DRBC 
or with 10 ~g of A45-Ficoll on day 0 and their spleens were assayed on day 4. 
heterogeneity only under special circumstances of immunization (12-14).  The 
present findings indicate that most secretory B-cell clones detectable as hapten- 
reactive  PFC  constitute more or  less  restricted  subcomponents of the  total 
secretory B-cell response. 
One might envisage similar circumstances of PFC detection if all hapten- 
specific assays were inherently inadequate; i.e.,  if by their very nature,  all 
hemolytic plaque  techniques were  of low  sensitivity.  Although PFC  assays 
employing small azo-haptens may suffer to some extent from this limitation, 
PFC procedures which use the enlarged azo-haptens usually have markedly 
increased sensitivity, even under circumstances in which immunization has 
been conducted with a small azo-hapten (Fig. 2). In separate studies, the large 
hapten assay systems have consistently detected from 90 to 98% of MOPC 315 
myeloma tumor cells as plaque formers (15). Since the large haptens all couple 
to SRBC by a common coupling reaction (4) it is also likely that the sensitivities 
for each of the large hapten assay  systems are closely comparable. Thus,  it 
appears that the enlarged hapten assay systems succeed in detecting nearly all 
of any given tip on the immune response iceberg. 
Since the PFC populations detected by the various hapten-reactive plaque 
assays are mostly separate and nonoverlapping (Tables II and HI), the ana- 
logue-reactive PFC account, in all probability, for some of the "nonspecific" new 
Ig produced in response to immunization (1, 2). Although much of this new Ig 
appears to have comparable specificities in both hemagglutination and hemoly- 
sis reactions (Fig. 4), it is quite conceivable that comparison by other less closely 
related immunologic procedures might reveal a  greater divergence of reactive 
specificities. In other words, many of the newly synthesized Ig molecules se- 
creted by analogue-reactive PFC might be perceived as "nonspecific" new Ig in 
other types of immunologic assays. 
Previous studies have established the existence of '~heteroclitic" antibodies 
(16, 17). These heteroclitic antibodies are generally defined as having a higher 386  DETECTION  OF  ALLOREACTIVE  PLAQUE-FORMING  CELLS 
TABLE  IV 
Classification  of  Hapten-Elicited PFC on the Basis of  Homologue and Analogue Plaque- 
Forming Reactivity 
Characteristics of Ig-secreting cells in hapten-  Traditional ter-  Suggested ter- 
reactive plaque formation*  minology  minology 
I.  Homologue-reactive,  Analogue-nonreactive  "Monospecific"  Homoreactive 
II.  Homologue-reactive,  Analogue~reactive  Cross-reactive  Cross-reactive 
III.  Homologue-nonreactive, Analogue-nonreactive  "Nonspecific"  Nonreactive 
IV.  Homologue-nonreactive, Analogue-reactive  (Unrecognized)  Alloreactive 
* In any hapten-elicited immune response, the recognizable size of each PFC compartment is 
determined operationally, i.e., largely by the number and sensitivity of the haptenic assay 
systems employed  in screening for Ig-secreting cells.  For example, as the number of assay 
systems is increased compartment IV tends to enlarge at the expense of compartment III. 
binding affinity for a cross-reacting determinant than for epitopes of  the original 
immunizing antigen. Heteroclitic antibodies have usually been detected only in 
limited  instances  (18, 19)  and  unlike the  antibodies  secreted  by  analogue- 
reactive PFC, heteroclitic antibodies have usually been defined in terms of their 
affinity rather than their functional reactivity. 
Analogue-reactive PFC are secreting Ig molecules which do not readily seem 
to fit the usual definitions for cross-reactive, for nonspecific, or even for hetero- 
clitic Ig molecules. Since hapten-reactive PFC can be conveniently defined in 
terms of their detectability on SRBC bearing either haptenic homologues or 
analogues, these relationships are set forth systematically in Table IV. Existing 
concepts include monospecific, cross-reactive, and nonspecific PFC, however the 
present findings suggest an additional category of  Ig-secreting cells which might 
best be  termed alloreactive,  i.e.,  they are  preferentially reactive  in  plaque 
formation with  alternative  or  analogue  structures  other than  the  eliciting 
hapten.  Since analogue-reactive or alloreactive PFC responses are  generally 
more numerous for specificities that represent closely related rather than dis- 
tantly  related  haptenic  analogues  (Figs.  1-4  and  6)  they  are  distinct from 
polyclonal, PFC responses which are usually of much lower amplitude and are 
not subject to recognizable specificity requirements (20-22). 
Alloreactive PFC populations have not been previously reported. Perhaps this 
is mainly because they have not been systematically sought. Alloreactive PFC 
populations exist in both direct (IgM) and indirect (IgG) immune responses (Fig. 
2). They are detectable by both traditional small hapten and enlarged spacer 
hapten assay  systems,  and they do not appear  to be  generally referable to 
antibody activities directed against bridge, spacer, or stem components of hap- 
tenic structures.  Such alloreactive PFC comprise a  large component of direct 
(especially early direct) PFC responses. It is not uncommon  for a single alloreac- 
tive PFC population to outnumber the population of PFC detectable on SRBC 
bearing the actual immunizing hapten (Figs. 1 F, 3, and 4 A). Alloreactive PFC 
appear in response to both thymic-dependent and thymic-independent antigens 
(Fig.  6).  And, they often comprise the major portion of hapten-elicited B-cell 
immune responses both in rabbits and in mice (Figs. 1 F and 3). 
Most B  cells which have matured to the  stage of active Ig secretion,  are 
committed to the synthesis of antibody molecules which are homogeneous in BRUCE  MERCHANT  AND  JOHN  K,  INMAN  387 
reactive specificity (23-25). In addition, secretory B cells rarely if ever-undergo 
capricious changes in specificity once secretion has commenced (6, 25, 26). Thus, 
the usual mature B cell appears to be highly differentiated  and "locked-in" to the 
production of a given pair of V-region structures. Numerous biosynthetic con- 
straints also appear to be imposed upon the immediate precursors of secretory B 
cells (27-29). It is generally assumed that a precursor B cell bearing Ig receptors 
committed to a given antigenic determinant will, on activation, give rise to a 
clone of cells producing antibody molecules of like  specificity. Considerable 
experimental evidence supports this view (30, 31). Thus there appear to be few if 
any "defections" of the Ig specificity commitments of individual B  cells from 
their precursor to their secretory stages. If these concepts are viewed as axio- 
matic, then the very existence of alloreactive PFC  challenges any simplistic 
interpretation of Ig receptor function in the B-cell activation process. Ig recep- 
tors may be viewed as playing either an active (32, 33) or a passive (22) role in B- 
cell activation. In either instance they are considered to play a specific or highly 
selective role. Our present findings suggest the existence of a substantial degree 
of cross-activation affecting B-cell  clones having favorable reactivities with 
analogues of the immunizing hapten.  Hapten inhibition  studies  of alloreac- 
tive PFC populations, should provide much useful information on the affinity 
and the  avidity characteristics of the Ig molecules they secrete.  Systematic 
studies of alloreactive PFC may ultimately provide fundamental insights into 
the  complex process  by  which B  precursor cells  are  activated to  secretory 
function.  Such studies may also  yield useful insights  into the  nature of Ig 
receptor participation in B-cell activation. 
Summary 
Immunization of rabbits or mice with a  single, chemically defined hapten 
elicits populations of plaque-forming cells (PFC) detectable not only on sheep 
erythrocytes (SRBC) bearing the immunizing hapten, but also on SRBC bearing 
structural analogues of the immunizing hapten.  Most of these analogue-reac- 
tive PFC preferentially lyse analogue-conjugated SRBC and cannot be detected 
on erythrocytes bearing the immunizing hapten. Thus, they represent hereto- 
fore largely unstudied components of the secretory B-cell response to haptenic 
immunization, and they have been termed alloreactive PFC. 
Such alloreactive PFC are detectable using either classical small haptens or 
tripeptide-enlarged counterparts of these classical haptens. They are present in 
large numbers both in direct and in indirect PFC assays, and they are elicited in 
response  to  both  thymic-dependent and  thymic-independent antigens.  Rela- 
tively few alloreactive PFC can be attributed to cells producing hapten-carrier 
or "bridge area"-specific antibodies. Since the antibodies released by alloreactive 
PFC can also be detected by passive hemagglutination, their presence does not 
appear attributable to vagaries of complement activation. 
Numerous coexisting alloreactive PFC populations are detectable after hap- 
tenic immunization. In early direct PFC  responses it is not uncommon for a 
single alloreactive PFC population to outnumber the population of PFC detecta- 
ble on SRBC bearing the actual immunizing hapten. These alloreactive PFC 
may be the source of at least some of the new "nonspecific" Ig which is formed at 388  DETECTION  OF  ALLOREACTIVE  PLAQUE-FORMING  CELLS 
the time of immunization but about which little is known for lack of available 
techniques.  Some possible implications of these findings on the specificity of B 
precursor cell activation are discussed. 
Received for publication 16 September 1976. 
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